6922 completed, 1911 unknown, 1550 recruiting, 1013 terminated. 3564 Not applicable, 2478 Phase 2, 1779 Phase 1, 1270 Phase 3, 1083 Phase 4.
Follow Kidney Diseases: new trials by email Literature Review of Kidney Diseases trials Research Report on Kidney Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Maastricht Investigation of Renal Function in Absence of- and Post- Contrast in Patients With eGFR LEss Than 30 serum creatinine assay - Acute Kidney Injury (Nontraumatic), Contrast-induced Nephropathy | Withdrawn | Maastricht University Medical Center | 2097-11-01 | 2023-10-19 | ||
| Time to Excretion of Contrast, a Maastricht Prospective Observational Study Contrast concentration in urine - Renal Insufficiency, Acute Kidney Injury | Withdrawn | Maastricht University Medical Center | 2097-11-01 | 2023-10-19 | ||
| Efficacy of Point-Of-Care Creatinine Assays in Patients With eGFR <30 Receiving Intravascular Contrast serum creatinine assay - Renal Insufficiency, Acute Kidney Injury | Withdrawn | Maastricht University Medical Center | 2097-05-01 | 2023-10-19 | ||
| MRI Technical Development and Applications in Kidney Disease Chronic Kidney Diseases, Kidney Transplantation | Not yet recruiting | University of Minnesota | 180 | 2028-06-30 | 2026-04-13 | |
| Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN) NM8074 - IgA Nephropathy | Phase 2 | Not yet recruiting | NovelMed Therapeutics | 10 | 2028-02-01 | 2026-04-13 |
| Precision-Medicine Diagnostic Support in Hospitalized Veterans With Acute Kidney Injury PRECISE-AKI Clinical Decision Support Tool - Acute Kidney Injury (AKI) | Not applicable | Not yet recruiting | VA Office of Research and Development | 60 | 2028-01-01 | 2025-10-16 |
| CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients With Refractory Systemic Lupus Erythematosus (GALLOP) CB-010 - Systemic Lupus Erythematosus, Lupus | Phase 1 | Withdrawn | Caribou Biosciences, Inc. | 2027-12-01 | 2025-09-19 | |
| Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy NM8074 - aHUS - Atypical Hemolytic Uremic Syndrome | Phase 2 | Not yet recruiting | NovelMed Therapeutics | 12 | 2027-11-01 | 2026-04-13 |
| Veteran Centered Meal Intervention in Chronic Kidney Disease Medically tailored meals (MTMs) - Chronic Kidney Disease | Not applicable | Not yet recruiting | VA Office of Research and Development | 100 | 2027-10-01 | 2026-09-03 |
| Amino Acid Therapy Evaluating the Incidence of New-Onset AKI Amino Acid infusion, Lactated Ringer Solution - Acute Kidney Injury | Phase 2 | Not yet recruiting | Children's Hospital Medical Center, Cincinnati | 270 | 2027-10-01 | 2026-10-21 |
| Technology-enabled Social Network Intervention to Increase Live Donor Kidney Transplantation Digital education outreach intervention for kidney transplant access and human guide, Digital education outreach intervention for kidney transplant access only (unguided) - End-Stage Renal Disease, Chronic Kidney Diseases | Not applicable | Not yet recruiting | State University of New York at Buffalo | 550 | 2027-10-01 | 2026-10-20 |
| Anti-Interleukin-6 (IL6) in Calciphylaxis Tocilizumab - Calciphylaxis | Phase 1 | Not yet recruiting | Boston Medical Center | 10 | 2027-09-01 | 2026-07-16 |
| A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney Diseases CD19-targeted iNKT Cell Injection - IgA Nephropathy (IgAN), Membranous Nephropathy | Early Phase 1 | Not yet recruiting | Grit Biotechnology | 30 | 2027-08-01 | 2026-09-11 |
| Trial Without Borders IMPLEMENT-CKD: IMPLEMENTation of Evidence-Based SGLT2i to Reduce Global Burden of Cardiovascular and Chronic Kidney Disease Implementation of recommendations - Implementation Research, Kidney Disease | Not yet recruiting | The University of Queensland | 1390 | 2027-07-01 | 2026-10-02 | |
| Heterozygous Individuals for AGXT and Kidney Stones Controlled Diet - Kidney Stone, Urolithiasis, Calcium Oxalate | Not applicable | Enrolling by invitation | University of Alabama at Birmingham | 4 | 2027-07-01 | 2026-08-31 |
| Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial Balstilimab, Biospecimen Collection, Botensilimab - Clear Cell Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v8 | Phase 2 | Recruiting | National Cancer Institute (NCI) | 16 | 2027-05-17 | 2026-10-21 |
| Kidney RISE: Randomized Integrated Supportive CarE Trial Kidney RISE - Chronic Kidney Disease (Stages 4 and 5) | Not applicable | Not yet recruiting | NYU Langone Health | 280 | 2027-05-01 | 2026-08-03 |
| Breakthrough - T1DM and Chronic Kidney Disease Tegoprubart, Islet Cell Transplant - Diabete Type 1, Chronic Kidney Disease | Phase 1 / Phase 2 | Recruiting | University of Chicago | 10 | 2027-04-29 | 2026-08-20 |
| Insights Into the Continuous Renal Replacement Therapy to Critical Ill Patients continuous renal replacement therapy - Continuous Renal Replacement Therapy (CRRT), Acute Kidney Injury | Not yet recruiting | University of Alberta | 100000 | 2027-03-31 | 2026-09-09 | |
| PATH-03 Paraguay Feasibility Study ePATH System will be used to create an endoAVF - Kidney Disease, End-Stage | Not applicable | Not yet recruiting | Pathfinder Medical | 20 | 2027-03-01 | 2026-09-17 |
Showing 20 of 13249. Sign in to see all of them.
Renal Insufficiency, Chronic (3071) · Kidney Failure, Chronic (1997) · Carcinoma, Renal Cell (1956) · Acute Kidney Injury (1614) · Renal Insufficiency (1370) · Kidney Neoplasms (956) · Diabetic Nephropathies (514) · Kidney Calculi (501) · Diabetes Mellitus (402) · Melanoma (366) · Diabetes Mellitus, Type 2 (361) · Hypertension (356) · Neoplasms (348) · Lupus Nephritis (331)
Female Urogenital Diseases and Pregnancy Complications (13248) · Female Urogenital Diseases (13247) · Male Urogenital Diseases (13247) · Urogenital Diseases (13230) · Urologic Diseases (13182) · Pathological Conditions, Signs and Symptoms (6801) · Renal Insufficiency (5943) · Pathologic Processes (5934) · Disease Attributes (5106) · Chronic Disease (4843) · Neoplasms by Site (2635) · Urogenital Neoplasms (2579) · Urologic Neoplasms (2562) · Neoplasms (2467)
Nivolumab (159) · Sunitinib (151) · pembrolizumab (151) · Cyclophosphamide (141) · Blood Specimen Collection (138) · Mycophenolic Acid (135) · Tacrolimus (124) · Everolimus (106) · dapagliflozin (96) · Sorafenib (93) · Saline Solution (92) · Standard of Care (90) · Prednisone (88) · Sodium Chloride (87) · Bevacizumab (86)
National Cancer Institute (NCI) (180) · Assiut University (160) · Novartis Pharmaceuticals (125) · Pfizer (119) · Bayer (108) · AstraZeneca (107) · Mayo Clinic (103) · Assistance Publique - Hôpitaux de Paris (98) · Amgen (92) · National Taiwan University Hospital (75) · Seoul National University Hospital (70) · Ain Shams University (69) · M.D. Anderson Cancer Center (68) · Hospices Civils de Lyon (65) · University of Colorado, Denver (65)
United States (4857) · China (1249) · France (1130) · Germany (868) · Canada (861) · United Kingdom (793) · Italy (745) · Spain (667) · South Korea (500) · Australia (449) · Netherlands (420) · Belgium (410) · Turkey (Türkiye) (397) · Poland (380) · Taiwan (378)
Alp Ikizler, MD (19) · Giuseppe Remuzzi, MD (16)
PMID 40576086, PMID 39356039, PMID 36005278, PMID 38299639, PMID 37146227, PMID 35224730, PMID 36791280, PMID 35018639, PMID 36416787, PMID 39513526, PMID 37916745, PMID 34778952, PMID 34519356, PMID 38770818, PMID 33107592, PMID 33314078, PMID 35224732, PMID 31401903, PMID 32390133, PMID 33586138, PMID 37870148, PMID 38189593, PMID 38682786, PMID 39963952, PMID 27238653, PMID 28410911, PMID 33783815, PMID 37651553, PMID 38018702, PMID 38724717, PMID 39878152, PMID 33283264, PMID 34164803, PMID 36472416, PMID 37528520, PMID 39607014, PMID 40337980, PMID 40465397, PMID 32588430, PMID 33782940, PMID 38864363, PMID 41385299, PMID 25577718, PMID 26032537, PMID 35230699, PMID 37250503, PMID 38837240, PMID 39151033, PMID 39171639, PMID 41805697
2023 (85), 2016 (60), 2018 (48), 2025 (43), 2017 (42), 2019 (41), 2014 (40), 2015 (39), 2008 (28), 2009 (25), U10CA180886 (22), P30CA033572 (21), P30CA043703 (14), U10CA098543 (14), 2005 (13)